Thyroid Hormones and Thyromimetics

Abstract

This chapter will provide an overview on the recent design principles and structure–activity relationship of thyroid hormones and thyromimetics. The prospects for the treatment of metabolic diseases, hypo‐ and hyperthyroidism, and cardiac disease with pharmacologically selective thyromimetics are considerable if cardiovascular acceleration and other adverse events can be avoided.